CAS Registry Services℠

Referencias CAS

La recopilación de referencias del CAS reúne y conecta el conocimiento científico/a de miles de revistas y otras fuentes de literatura publicadas en todo el mundo en más de 50 idiomas que se remontan a principios del siglo XIX.

Contacto con nosotros
Hexagon shaped overlay
Pipette inserting blue liquid into a small vial among multiple vials with purple caps in a laboratory setting.

Características

Coverage of international journals, books, conference proceedings, and dissertations since 1907, with some earlier coverage back to the early 1800s.

Includes content from 50,000 scientific journal titles worldwide over the years, with thousands of current titles actively covered.

English language titles and summaries translated by CAS scientists from publications in more than 50 different languages from more than 180 different countries.

Searchable details include standardized concept keywords, substances, reactions, and more indexed by scientists and connected to other relevant data within the CAS Content Collection™.

Enhanced with cited and citing references and direct links to the full-text publications (where available).

Updated daily.

Latest from CAS Insights™

Drug Discovery

AI in drug discovery: Moving from potential to practical

CAS hosted Life Sciences Summits across three regions in 2025, exploring practical AI integration in drug discovery. Learn about data governance, implementation barriers, and modality-specific challenges.
|Article
Ciencia emergente

Nipah virus explained: Risks, realities, and the hope from new research

New Nipah cases in India have renewed focus on a high‑fatality zoonotic threat shaped by complex spillover dynamics, severe neurological disease, and limited medical countermeasures. Meanwhile, global efforts in diagonistcs, therapeutics, and vaccines are accelerating.
|Article
Biotechnology

Innovaciones en la inmunoterapia del cáncer: los captadores biespecíficos de células T

Los activadores biespecíficos de las células T están a punto de convertirse en tratamientos de inmunoterapia clave debido a la simplificación de la producción y a los nuevos avances de seguridad.
|Article